MedTrace Logo

Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss

NCT06792110 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-24

No results posted yet for this study

Summary

The goal of this clinical trial will be to evaluate the efficacy of artificial intelligence-integrated hearing aids in individuals with hearing loss. The main questions to answer are:

1. How effective is an artificial intelligence integrated hearing aid in improving speech perception in noise.
2. How does an artificial intelligence integrated hearing aid compare to currently available commercial hearing aids.

Conditions

Interventions

DEVICE

Artificial Intelligence Integrated Hearing Aid Use

Participants in this arm will use the study-designed artificial intelligence-integrated hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.

DEVICE

Phonak Infineo Hearing Aid

Participants in this arm will use a fitted commercial hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.

DEVICE

Oticon Real Hearing Aid

Participants in this arm will use a fitted commercial hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.

Sponsors & Collaborators

Principal Investigators

  • Gavriel Kohlberg, MD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-02-28
Completion
2026-07-01
FDA Device
Yes

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06792110 on ClinicalTrials.gov